Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis.
Yi-Fang TsaiChi-Cheng HuangYen-Shu LinChih-Yi HsuChing-Po HuangChun-Yu LiuJen-Hwey ChiuLing-Ming TsengPublished in: Cancer immunology, immunotherapy : CII (2021)
We conclude that IL-17A promotes migratory and angiogenic activity in tumors, enhances anoikis resistance, and modulates the immune landscape of the tumor microenvironment such changes favor cancer metastasis.